Drug delivery, formulation

Prostate cancer drug demonstrates major survival benefit

02-Mar-2021 By Jenni Spinner

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.

FDA approves injectable treatment for HIV patients

25-Jan-2021 By Jenni Spinner

The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.

Grifols to launch trial for potential COVID-19 therapy

19-Jan-2021 By Jenni Spinner

The subcutaneously administered immunoglobulin, if successful, would provide rapid immunity against the virus behind the deadly global pandemic.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

Ingredients, innovation and a need for speed: what’s in store for 2021

23-Dec-2020 By Jenni Spinner

Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.

Biomarkers pave the way to personalized care: Quanterix

21-Dec-2020 By Jenni Spinner

An executive from the digital biomarker tech company explains the myriad benefits of biomarker analysis in advancing precision health solutions.

Chicago life-sciences incubator to open in early 2021

14-Dec-2020 By Jenni Spinner

The resource—designed to provide seed capital, lab space, offices and management consulting to researchers—is opening its doors earlier than expected.

Latest FDA COVID-19 news

03-Dec-2020 By Jenni Spinner

As the pandemic continues to impact the globe, the agency has kept busy issuing EUAs for potential treatments, and cited sellers of unapproved treatments.

Synairgen joins with Parexel Biotech to study COVID-19 drug

24-Nov-2020 By Jenni Spinner

The two companies will collaborate on a Phase III clinical trial investigating a potential treatment for patients hospitalized with COVID-19.

Pfizer: collaboration key to clinical care

18-Nov-2020 By Jenni Spinner

An expert from the global pharmaceutical firm shares how working with other organizations and putting patients at the center can benefit clinical research.

Latest FDA updates on COVID-19 battle

12-Nov-2020 By Jenni Spinner

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

Emerson, Integra CMS collaborate on continuous pharma manufacturing technology

04-Nov-2020 By Jenni Spinner

The two firms are joining forces to help life-sciences customers speed up adoption of continuous manufacturing in pharmaceutical processes.

TraceLink launches intelligent product serialization technology

03-Nov-2020 By Jenni Spinner

The Serialized Product Intelligence application uses serialization data to help operations streamline supply-chain operations, resolve issues and more.

WuXi STA: increasing demand fueling ‘robust’ HPAPI market

29-Oct-2020 By Jenni Spinner

A leader from the STA Pharmaceutical subsidiary of WuXI AppTec talks about the dynamic HPAPI market and what’s ahead for their operation.

TFF Pharmaceuticals partners with Experic to expand manufacturing

26-Oct-2020 By Jenni Spinner

The clinical-stage pharma firm will install a processing line at Experic’s cGMP facility in New Jersey to handle its thin-film freezing technology.

Enosi: COVID-19 adds to autoimmune challenges

26-Oct-2020 By Jenni Spinner

A leader from the drug research and development company discusses unique problems faced by COVID-19 patients with prior cancer and autoimmune diagnoses.

Premier Research: holistic approach benefits drug development

06-Oct-2020 By Jenni Spinner

A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.

FDA COVID-19 response roundup

05-Oct-2020 By Jenni Spinner

As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.

CPhI Festival of Pharma

Vetter to profile cleanroom concept at CPhI

30-Sep-2020 By Jenni Spinner

The aseptic technology specialist plans to discuss its V-CRT cleanroom technology at the upcoming CPhI Festival of Pharma online event in October.

CPhI Festival of Pharma

Noble to address drug delivery evolution at CPhI

30-Sep-2020 By Jenni Spinner

A leader from the pharma solutions firm will discuss the future of drug delivery at a keynote during the CPhI Festival of Pharma virtual event.

Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations

14-Sep-2020 By Rachel Arthur

Merck and Seattle Genetics have announced two strategic oncology collaborations: one to develop Seattle Genetics’ antibody-drug conjugate ladiratuzumab vedotin worldwide; and another to accelerate the global reach of Tukysa (tucatinib).

FSD Pharma announces Phase II trial for potential COVID-19 treatment

08-Sep-2020 By Jenni Spinner

The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.

Thermo Fisher expands cryo-EM access

31-Aug-2020 By Jenni Spinner

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

Colorcon invests in AI-centric drug discovery

24-Aug-2020 By Jenni Spinner

The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery

Research partnership delves into opioid alternatives

03-Aug-2020 By Jenni Spinner

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

Lonza: the right bio model can make a difference

27-Jul-2020 By Jenni Spinner

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

Absorption Systems: complex generics offer obstacles, opportunities

21-Jul-2020 By Jenni Spinner

A leader from the CRO shares perspectives on the challenges and rewards associated with the category, and approaches in getting generics to market.

Aigenpulse launches AI-based discovery platform

20-Jul-2020 By Jenni Spinner

The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.

Syneos Health inks service deal with Pfizer

16-Jul-2020 By Jenni Spinner

The clinical development and consulting firm has signed a three-year service agreement to support the pharma firm with development service solutions.

Sandoz, Civica RX partner to stem shortage of generics

09-Jul-2020 By Jenni Spinner

The two companies plan to join forces in order to help healthcare providers anticipate and avoid shortages of critical injectable generic medications.

Thermo Scientific workflow aims to accelerate drug development

29-Jun-2020 By Jenni Spinner

The iSPA Workflow, using single-particle analysis technology, is intended to help pharmaceutical bring drugs to market faster while conserving costs.

Idifarma: Spray-drying highly potent drugs a key growth factor

24-Jun-2020 By Jenni Spinner

The CDMO has begun manufacturing of highly potent APIs at a dedicated area in its GMP plant, geared toward niche products and clinical batches.

HPAPI Summit tackles trends and technology

24-Jun-2020 By Jenni Spinner

The ninth annual event, taking place in Boston mid-November, will feature industry professionals addressing manufacturing practices, regulatory updates and market trends.

Gilead gets green light for inhaled remdesivir study

23-Jun-2020 By Jenni Spinner

After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.

Evonik launches Resomer Precise custom functional excipients

15-Jun-2020 By Jenni Spinner

The company reportedly is harnessing sophisticated technology to enable process validation of polymers to tight specifications in parenteral drugs.

ArisGlobal launches LifeSphere Regulatory platform

10-Jun-2020 By Jenni Spinner

The drug development software specialist has introduced technology designed to streamline regulatory information management.

Latest FDA COVID-19 updates

27-May-2020 By Jenni Spinner

The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.

Noxopharm reports positive results for prostate cancer drug

26-May-2020 By Jenni Spinner

The oncology drug development firm has announced 27% abscopal response in soft-tissue lesions with use of Veyonda and low-dose radiotherapy.

Avalere: FDA can impact COVID-era drug development

18-May-2020 By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

Nanoform granted GMP certification

14-May-2020 By Jenni Spinner

The Finnish nanoparticle technology specialist’s facility has been given the stamp of approval by the Finnish Medicines Agency.

Quartic.ai, Bright Path Labs to partner on AI-powered API manufacturing

11-May-2020 By Jenni Spinner

The two firms are joining forces to develop AI-based technology for continuous manufacturing of critical APIs necessary for producing crucial small-molecule drugs.

Weekly FDA COVID-19 update

07-May-2020 By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

3M Drug Delivery Systems relaunches as Kindeva Drug Delivery

04-May-2020 By Jenni Spinner

The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.

Almac Discovery collaborates with Merck on DUB targets

30-Apr-2020 By Jenni Spinner

The partnership will focus on generating novel small-molecule inhibitors against specific DUB targets for treatment of a range of diseases.

Butterworth Labs adopts COVID-19 crisis measures

27-Apr-2020 By Jenni Spinner

The pharmaceutical analysis firm is continuing its contract analytical laboratory services running, with changes designed to keep people and products safe.

Vanda Pharmaceuticals partners with UIC on COVID-19 research

21-Apr-2020 By Jenni Spinner

The company and the University of Illinois at Chicago will work together to identify novel antivirals against COVID-19.

FDA COVID-19 response roundup

08-Apr-2020 By Jenni Spinner

The federal agency continues to take action and make announcements centered on nationwide efforts to combat the virus causing the global pandemic.

FDA updates and actions on COVID-19

01-Apr-2020 By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

SPI Pharma expands line of mannitol products

30-Mar-2020 By Jenni Spinner

The company has added four mannitols to its Mannogem line, designed for optimal compressibility, binding, disintegration and particle size ranges.

PolarisQB, Fujitsu partner on drug discovery

24-Mar-2020 By Jenni Spinner

The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases.